John Nottingham
Co-president
Nottingham Spirk
John Nottingham is co-president of Nottingham Spirk, a leading business and product innovation firm with 1,250 patents, of which 95% have been commercialized. The Nottingham Spirk "Vertical Innovation" process has helped client/partner companies earn more than $50 billion in combined sales.
The NS innovation team has co-created award-winning medical and consumer innovations such as Cardinal Health InPower Digital Medication Assistant; Crest SpinBrush, the largest selling powered toothbrush line; TecTraum, the first concussion therapy system; XaTec, the only blood monitor for anti-coagulant drugs, like Xarelto; Sterifre, the first low-cost, rapid point-of-care disinfection system; ThermoScan, the first digital ear thermometer; ViewRay, the first MRI guided radiation therapy device; and Medtronic CardioInsight EC Vue, the first non-invasive electrocardiographic mapping system.
John Nottingham serves on the Cleveland Clinic Board of Trustees, Case Western Reserve University Technology Commercialization Board, boards of CWRU think[box] maker space, Global Center for Health Innovation, Great Lakes Biomimicry, as well as several private equity company boards of directors.
John is a 2018 Fellow of the National Academy of Inventors. As the lead patent holder on hundreds of U.S. and international patents, he is in the top tier of individual inventors in the U.S. John is an inductee of the Inside Business Hall of Fame and a 2017 winner of the EY Entrepreneur of the Year Award.
John has presented numerous times on the subject of breakthrough innovation, and has shared speaker platforms with Neil Armstrong, Colin Powell and Clayton Christensen, author of "The Innovator's Dilemma." He has been featured on The Today Show, CNN, NBC Nightly News, Wall Street Journal, Fortune, Forbes, Japan Forbes, Bloomberg BusinessWeek, New York Times, Wired and Fast Company.
Learn more about John: https://www.linkedin.com/in/john-nottingham-a359a9a/